Nantahala Capital Management, LLC Keros Therapeutics, Inc. Transaction History

Nantahala Capital Management, LLC

$1.55 Billion
Q1 2024

A detailed history of Nantahala Capital Management, LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 293,997 shares of KROS stock, worth $13.4 Million. This represents 1.25% of its overall portfolio holdings.

Number of Shares

293,997

Previous 310,141 5.21%

Holding current value

$13.4 Million

Previous $12.3 Million 57.83%

% of portfolio

1.25%

Previous 0.83%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$41.26 - $70.48 $666,101 - $1.14 Million	-16,144 Reduced 5.21%	293,997 $19.5 Million
Q4 2023 Feb 14, 2024	SELL	$27.12 - $41.05 $505,516 - $765,172	-18,640 Reduced 5.67%	310,141 $12.3 Million
Q3 2023 Nov 14, 2023	SELL	$31.57 - $43.02 $5.32 Million - $7.24 Million	-168,380 Reduced 33.87%	328,781 $10.5 Million
Q2 2023 Aug 14, 2023	SELL	$37.26 - $51.01 $9.15 Million - $12.5 Million	-245,658 Reduced 33.07%	497,161 $20 Million
Q1 2023 May 15, 2023	SELL	$41.44 - $59.32 $2.04 Million - $2.92 Million	-49,274 Reduced 6.22%	742,819 $31.7 Million

Q4 2022 Feb 14, 2023	SELL	$39.45 - $51.77 $2.11 Million - $2.77 Million	-53,599 Reduced 6.34%	792,093 $38 Million
Q3 2022 Nov 10, 2022	SELL	$27.8 - $40.12 $1.84 Million - $2.66 Million	-66,209 Reduced 7.26%	845,692 $31.8 Million
Q2 2022 Aug 15, 2022	BUY	$26.03 - $67.04 $2.47 Million - $6.37 Million	95,071 Added 11.64%	911,901 $25.2 Million
Q1 2022 May 13, 2022	BUY	$42.12 - $59.36 $847,959 - $1.2 Million	20,132 Added 2.53%	816,830 $44.4 Million
Q4 2021 Feb 14, 2022	BUY	$36.95 - $62.89 $1.34 Million - $2.28 Million	36,315 Added 4.78%	796,698 $46.6 Million
Q3 2021 Nov 15, 2021	BUY	$29.27 - $43.71 $4.73 Million - $7.06 Million	161,503 Added 26.97%	760,383 $30.1 Million
Q2 2021 Aug 16, 2021	BUY	$42.4 - $70.11 $5.87 Million - $9.71 Million	138,508 Added 30.09%	598,880 $25.4 Million
Q1 2021 May 14, 2021	SELL	$54.0 - $75.28 $4 Million - $5.58 Million	-74,142 Reduced 13.87%	460,372 $28.3 Million
Q4 2020 Feb 16, 2021	BUY	$36.0 - $82.74 $9.28 Million - $21.3 Million	257,687 Added 93.09%	534,514 $37.7 Million
Q3 2020 Nov 16, 2020	BUY	$27.04 - $62.21 $49,402 - $113,657	1,827 Added 0.66%	276,827 $10.7 Million
Q2 2020 Aug 14, 2020	BUY	$20.08 - $40.39 $5.52 Million - $11.1 Million	275,000 New	275,000 $10.3 Million

Others Institutions Holding KROS

# of Institutions

153

Shares Held

26.7M

Call Options Held

47.6K

Put Options Held

34.5K

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.18B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Account

Nantahala Capital Management, LLC Keros Therapeutics, Inc. Transaction History